These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22970688)

  • 1. "Drugs on oxygen": an update and perspective on the role of cytochrome P450 testing in pharmacology.
    Tralau T; Luch A
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1357-62. PubMed ID: 22970688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro approaches to investigate cytochrome P450 activities: update on current status and their applicability.
    Ong CE; Pan Y; Mak JW; Ismail R
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1097-113. PubMed ID: 23682848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast regulation of cytochrome P450 activities by phosphorylation and consequences for drug metabolism and toxicity.
    Oesch-Bartlomowicz B; Oesch F
    Biol Chem; 2002 Oct; 383(10):1587-92. PubMed ID: 12452435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.
    Strolin Benedetti M; Whomsley R; Baltes E
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):895-921. PubMed ID: 17125408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytochrome P450 isoenzymes in metabolism of endo- and exogenic compounds].
    Wiśniewska A; Mazerska Z
    Postepy Biochem; 2009; 55(3):259-71. PubMed ID: 19928582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
    Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
    Murray M
    Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A basic conceptual and practical overview of interactions with highly prescribed drugs.
    Dresser GK; Bailey DG
    Can J Clin Pharmacol; 2002; 9(4):191-8. PubMed ID: 12584577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.
    Shephard EA; Phillips IR
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1083-94. PubMed ID: 20629583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
    Muruganandan S; Sinal CJ
    Clin Pharmacol Ther; 2008 Jun; 83(6):818-28. PubMed ID: 18388875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of drug metabolism--implications for drug interaction].
    Sitkiewicz D
    Pol Merkur Lekarski; 2000 Sep; 9(51):595-7. PubMed ID: 11126981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
    Masubuchi Y; Horie T
    Crit Rev Toxicol; 2007 Jun; 37(5):389-412. PubMed ID: 17612953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
    McGinnity DF; Parker AJ; Soars M; Riley RJ
    Drug Metab Dispos; 2000 Nov; 28(11):1327-34. PubMed ID: 11038161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemically driven drug metabolism by membranes containing human cytochrome P450.
    Mie Y; Suzuki M; Komatsu Y
    J Am Chem Soc; 2009 May; 131(19):6646-7. PubMed ID: 19402636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics.
    Martinez MN; Antonovic L; Court M; Dacasto M; Fink-Gremmels J; Kukanich B; Locuson C; Mealey K; Myers MJ; Trepanier L
    Drug Metab Rev; 2013 May; 45(2):218-30. PubMed ID: 23432217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.